Xiaoling Mu

No ORCID on file · 3 papers in corpus
observational 2023
The value of serum HE4 and CA125 levels for monitoring the recurrence and risk stratification of endometrial endometrioid carcinoma
Heliyon ·doi:10.1016/j.heliyon.2023.e18016

To evaluate the role of serum human epididymis secretory protein 4 (HE4) and carbohydrate antigen 125 (CA125) levels for predicting and monitoring the recurrence of endometrial endometrioid carcinoma (EEC) and assessing preoperative risk st…

diagnostic-accuracy 2021
Diagnostic Value of Preoperative CA125, LDH and HE4 for Leiomyosarcoma of the Female Reproductive System
Cancer management and research ·doi:10.2147/cmar.s302223

PURPOSE: Leiomyosarcoma (LMS) is a rare and extremely aggressive malignancy that is derived from or shows evidence of differentiation toward smooth muscle. If LMS occurs in the female reproductive system, preoperative diagnosis can be diffi…

other 2021
Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma
Scientific reports ·doi:10.1038/s41598-021-01263-w

There is no recognized serum biomarker to predict the recurrence of endometrial carcinoma (EC). We aimed to explore serum human epididymis protein 4 (HE4) and cancer antigen 125 (CA125) as the biomarkers to predict and monitor recurrence of…